Testosterone Suppresses IL‐17 Expression by Targeting RORγt Functions
European Journal of Immunology · 2025
DOI: 10.1002/eji.70016 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Akshay Binayke und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Core Laboratory, Translational Health Science and Technology Institute, Faridabad, India. Hauptthemen laut MEDLINE: Nuclear Receptor Subfamily 1, Group F, Member 3, Testosterone, Interleukin-17, Th17 Cells. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Translational Health Science and Technology Institute.
Abstract (Originalsprache)
Th17 cells play a crucial role in autoimmune disease pathogenesis. However, the mechanisms behind the sex differences in immune responses, particularly women's higher susceptibility to autoimmune diseases, remain unclear. This study investigated the role of testosterone in modulating the IL‐17 response. IL‐17 levels and IL‐17‐expressing cells were compared between males and females, and testosterone's effect on Th17 differentiation was evaluated. In an imiquimod‐induced psoriasis mouse model, testosterone supplementation reduced psoriasis severity in female mice, whereas castration of male mice exacerbated psoriasis. Testosterone inhibited both in vitro Th17 differentiation and in vivo IL‐17 expression, correlating with reduced psoriasis severity. Molecular studies indicated that testosterone is an inverse agonist of related orphan receptor gamma (RORγt), a key transcription factor for IL‐17 expression. These findings offer mechanistic insights into how testosterone limits tissue inflammation in psoriasis and suggest a basis for developing novel testosterone derivatives to target RORγt and suppress Th17‐mediated inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Core Laboratory, Translational Health Science and Technology Institute, Faridabad, India.
- Centre for Immunobiology and Immunotherapy, Translational Health Science and Technology Institute, Faridabad, India.
- Translational Health Science and Technology Institute, Faridabad, India.
ORCID-Profile: Akshay Binayke, Amit Awasthi
Förderung
- Translational Health Science and Technology Institute
Zitieren
APA
Binayke, A., Dalal, R., Suri, C., Dandotiya, J., Sadhu, S., Kumar, Y., Asthana, S., Rathore, D. K., & Awasthi, A. (2025). Testosterone Suppresses IL‐17 Expression by Targeting RORγt Functions. European Journal of Immunology. https://doi.org/10.1002/eji.70016
Vancouver
Binayke A, Dalal R, Suri C, Dandotiya J, Sadhu S, Kumar Y, et al. Testosterone Suppresses IL‐17 Expression by Targeting RORγt Functions. European Journal of Immunology. 2025. doi:10.1002/eji.70016
BibTeX
@article{Binayke2025,
author = {Binayke, Akshay and Dalal, Rajdeep and Suri, Charu and Dandotiya, Jyotsna and Sadhu, Srikanth and Kumar, Yashwant and Asthana, Shailendra and Rathore, Deepak Kumar and Awasthi, Amit},
title = {Testosterone Suppresses IL‐17 Expression by Targeting RORγt Functions},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.70016}
}
EUVIMED